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Available online 14 September 2012Diabetes mellitus affects the brain. Both type 1 and type 2 diabetic patients are associated with white matter
(WM) damage observable to diffusion tensor imaging (DTI). The underlying histopathological mechanisms,
however, are poorly understood. The objectives of this study are 1) to determine whether streptozotocin
(STZ)-induced type 1 diabetes is associated with WM damage observable to DTI; and 2) to understand the
pathophysiological aspects underlying STZ-induced brain injuries. Male Sprague–Dawley rats received a single in-
traperitoneal injection of STZ (62 mg/kg). DTI was used to assess brain abnormalities at 4 weeks after induction,
combined with histological assessments and ultrastructural analysis. Compared to controls, the STZ-induced rats
showed signiﬁcantly reduced fractional anisotropy (FA) in the motor/somatosensory cortex and striatum. Histo-
logically, the cortex and striatum of the diabetic animals are characterized by demyelination and axonal degrada-
tion. In conclusion, STZ-induced diabetes is associated with striatal/cortical injuries observable to DTI. The DTI
abnormalities are likely manifestations of demyelination and axonal degradation in the affected brain regions,
and can potentially be used as surrogates for evaluating diabetic brain injuries.
© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Patients with diabetes mellitus, and in particular those with poor
glycemic control, often experience brain complications (van Harten
et al., 2006). It is well known that long-standing diabetes increases
the risk of brain atrophy, lacunar infarcts and white matter (WM) le-
sions. The functional/behavioral consequences of diabetic brain com-
plications include cognitive dysfunction and movement disorders
(Shan et al., 1998; van Elderen et al., 2010; van Harten et al., 2006).
Diffusion tensor imaging (DTI) is a magnetic resonance imaging
(MRI) technique that has been increasingly used in the diagnosis and
prognosis of WM diseases (Tournier et al., 2011). Parametric diffusion
indices derived from DTI, such as fractional anisotropy (FA) and direc-
tional diffusivity are often used to assess microstructural changes of
brain tissues (Tournier et al., 2011).
Only few previous studies have assessed WM damage in diabetic
patients with DTI. It was shown that patients with long-standingics and Mathematics, Chinese
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nc. Open access under CC BY-NC-ND ltype 1 diabetes had signiﬁcantly reduced FA in the posterior corona
radiata and optic radiation, which correlated with the duration of di-
abetes (Kodl et al., 2008). These patients also had signiﬁcantly re-
duced cortical thickness in brain regions with high connectivity to
the injured WM tracts (Franc et al., 2011). DTI assessment among in-
dividuals with type 2 diabetes demonstrated diffuse but predomi-
nantly frontal and temporal WM microstructural abnormalities (Yau
et al., 2009). A more recent DTI study found that, compared to the
control, type 2 diabetic patients had signiﬁcantly increased mean diffu-
sivity (MD) of the brain parenchyma and signiﬁcantly decreased FA in
the bilateral frontal WM (Hsu et al., 2012). They further showed that
therewas a signiﬁcant association between disease duration andmicro-
structural properties in the bilateral cerebellum, temporal lobe WM,
right caudate and bilateral cingulate gyrus (Hsu et al., 2012).
In a mouse model of streptozotocin (STZ)-induced type 1 diabetes,
WMchanges and brain atrophywere detected 8 months after induction
(Francis et al., 2008). Yang et al. showed that T2-weighted and magne-
tization transfer MRI can be used to assess WM abnormalities in rats
with type 1 diabetes or type 2 diabetes, and the changes of MRI signal
intensity are associated with loss of myelin proteins and oligodendroglia
(Yang et al., 2011).
In this study, we used DTI to assess brain abnormalities in a rat model
of STZ-induced type 1 diabetes at 4 weeks after induction. The imaging
results were correlated to those of histological assessments and ultra-
structural analysis. The main purposes of the study are 1) to determine,
without glycemic control, whether STZ-induced type 1 diabetes canicense.
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physiological aspects underlying STZ-induced brain injuries.
Materials and methods
Animals
All animal protocols were approved by the Institutional Animal Care
and Use Committee. Forty male Sprague–Dawley rats, about 10 weeks
old and weighing about 300 g, were obtained from the Experimental
Animal Center, Wuhan University. Type 1 diabetes (n=24) was induced
by a single intraperitoneal injection of streptozotocin (62 mg/kg) (Sigma,
St. Louis, MO) dissolved in 0.01 mol/L citric acid solution (pH=4.5).
The control animals (n=16) were injected with the same amount of
solvent. The animals were then housed individually in a temperature-
and humidity-controlled environment on a 12-h light/dark cycle. To
prevent hypoglycemia, the STZ-induced rats were allowed to have
free access to D5W (water with 5% dextrose) during the ﬁrst 24 h
after STZ injection. Three days after the induction, fasting blood glucose
levels and bodyweightsweremeasured. Six STZ-induced rats that had a
fasting blood glucose level less than 13.5 mmol/L were excluded. Fasting
blood glucose level and body weight weremeasured weekly for the next
4 weeks.
MRI acquisition
All magnetic resonance experiments were performed on a 7 T/
20-cm-diameter bore Bruker Biospec scanner at 4 weeks after STZ in-
duction. A volume coil was used for radiofrequency transmission, and a
quadrature surface coil for signal detection. DTI was performed with a
4-shot spin-echo echo planar imaging sequence, an encoding scheme
of 30 gradient directions homogenously distributed on the unit sphere
and the following parameters: repetition time (TR) 5000 ms, echo time
(TE) 26 ms,ﬁeld of view (FOV) 3 cm×3 cm, slice thickness 0.8 mm,ma-
trix size 128×128, Δ 14 ms, δ 3 ms, two b values of 0 and 800 s/mm2
and 4 averages. The animals were anesthetized by 1.5–2% isoﬂurane in
pure O2 delivered via a nose cone during the imaging sessions.
Histology and immunohistochemistry
After being imaged, three randomly selected rats from each group
were anesthetized with an overdose of 5% chloral hydrate, and per-
fused transcardially with 0.9% saline and 4% paraformaldehyde in
phosphate-buffered solution (PBS). The brains were immediately re-
moved and postﬁxed in the same ﬁxative at 4 °C until being sectioned
on a cryostat (Leica, Germany). Coronal brain sections 10 μm-thick were
obtained and stored at−20 °C until use.
Bielschowsky's sliver (BS) stainingwas used to assess themorpholo-
gy and integrity of axons and neuropil. The brain sections were washed
with distilled water and incubated in 10% silver nitrate solution for
35–40 min at room temperature. The sections were then processed se-
quentially with a 5%methanal solution for 5 min, a 10% ethanol solution
for 2 min, a silver amino solution for 2 min and a 10%methanal solution
for 5 min, followed by washes with distilled water and dehydration in
100% ethanol.
Klüver–Barrera (KB) staining was used for demonstrating the exis-
tence of myelin. The brain sections were incubated with a 0.1% Luxol
fast blue (LFB) solution at 60 °C overnight and rinsed with a 95% etha-
nol solution and distilledwater. The brain sectionswere then immersed
in a 0.05% lithium carbonate solution for 1 min and a 70% ethanol solu-
tion for 2 min, and treated with 0.1% cresyl violet and rinsed with 95%
ethanol. Finally, the sections were dehydrated in 100% ethanol, cleared
with xylene and mounted.
Nissl stainingwas used to assess neuronal damage in the cortex. The
brain sections were incubatedwith a 5% toluidine blue solution at roomtemperature for 15 min. Following rinses with tap water, the sections
were dehydrated and mounted.
Diminution in neuroﬁlament immunostaining of SMI-31 is usually
considered a sign of axonal degeneration (Budde et al., 2007). For
SMI-31 immunohistochemistry, the brain sections were pre-incubated
with a 0.01 M citrate buffer (pH 6.0) at 80–85 °C for about 10 min,
until the temperature of the antigen retrieval solution had reached
room temperature. After a brief wash in 0.01 M PBS, the brain sections
were incubated in 0.2% Triton X-100 at 37 °C for 30 min, washed in
0.01 M PBS and then incubated with 10% normal goat serum at 37 °C
for 40 min. Subsequently, the brain sections were incubated in anti-
phosphorylated neuroﬁlaments SMI-31 antibody (diluted 1:1000 in
PBS; Sternberger Monoclonals Lutherville, Maryland) at 37 °C for 1 h
and then at 4 °C for additional 21 h. Further washes with 0.01 M PBS
were performed before incubation in Alexa 488-rabbit anti-goat IgG an-
tibody (diluted 1:200 in 0.01 M PBS) at 37 °C for 1 h. The sections were
washed with 0.01 M PBS and dehydrated before being mounted.
Methylene blue staining was used for morphometric analysis of
myelinated axons. Transmission electron microscopy was used for ultra-
structural assessments of myelin integrity and axonal injuries. Samples
from the striatum and cortex were collected and ﬁxed with 2.5 wt.%
glutaraldehyde dissolved in 0.01 M PBS (pH 7.4). The samples were
postﬁxed with 1% osmium tetroxide, dehydrated, embedded in resin
and sectioned to 80 nm- or 1 μm-thick slices. The 1 μm-thick slices
were stained with methylene blue. The 80 nm-thick slices were stained
with uranyl acetate and lead citrate for ultrastructural tissue examination
under an H-7000FA transmission electron microscope (Hitachi, Japan).
Image pre-processing
The DTI data from two rats in the STZ-induced groupwere excluded
because of poor image quality. As a result, the DTI data from a total of
sixteen rats in the STZ group and sixteen rats in the control group
were included in the ﬁnal analysis. For each animal, the FMRIB's Diffu-
sion Toolbox in FSL (http://www.fmrib.ox.ac.uk/fsl) was used to realign
diffusion-weighted images to corresponding non-diffusion-weighted
(b=0) imageswith an afﬁne transformation tominimize image distor-
tion due to eddy currents. The diffusion tensor for each voxel was esti-
mated by a multivariate linear ﬁtting algorithm, and then diagonalized
to obtain its eigenvalues (λ1, λ2, λ3). The voxel-wise values of FA, axial
diffusivity (λ1, Da) and radial diffusivity ((λ2+λ3)/2, Dr) were calculat-
ed. Residual maps were calculated as previously described to evaluate
the accuracy of tensor ﬁtting (Tournier et al., 2011).
Voxel-based analysis of DTI data
Voxel-based analysis (VBA) of FA datawas performed using statistical
parametric mapping (SPM8, http://www.ﬁl.ion.ucl.ac.uk/spm/). The fol-
lowing processing schemes were used: (1) creating population-speciﬁc
template. First, the b=0 image of one representative control rat was
trilinearly interpolated into an isotropic voxel size of 0.117 mm3 and
used as the initial template. Then the b=0 images of all the other
(including control and STZ-induced) animals were co-registered to
this initial template using afﬁne transformation. A population-
speciﬁc template was then created by averaging the normalized images;
(2) VBA on FA. The b=0 image of each rat was co-registered to the
population-speciﬁc template using afﬁne transformation. For each indi-
vidual animal, the same transformationmatrix was applied to normalize
the FA maps spatially. All normalized FA images were then smoothed
with an isotropic 0.351-mm (3 times the dimension of the isotropic
voxel after interpolation) full width at half maximum (FWHM) Gaussian
kernel to reduce the effect of misregistration in spatial normalization.
The normalized and smoothed FA images were then analyzed voxel-
wise by SPM8 within the framework of general linear model. Only the
pixels where all rats had a FA value greater than 0.15 were analyzed.
This empirical cut-off valuewas used to eliminateﬁctitious results arising
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being WM, such as the CSF voxels (Hugenschmidt et al., 2008). The t
maps were thresholded using a conﬁdence level of pb0.005 (t>3) and
an extent cluster size greater than 10 contiguous voxels.
Histogram and region of interest (ROI) analysis of DTI data
The DTI changes in the striatum and cortex were further analyzed
by histogram and ROI analysis as previously described (Yu et al.,
2006). Masks of the bilateral striatum and cortex (Figs. 2 and 3)
were derived manually from the FA template. The ROI representing
bilateral striatum spanned 24 interpolated slices from Bregma 2.52
to 0. The ROI representing bilateral cortex spanned 43 interpolated
slices from Bregma 3.00 to −0.60. The resulting masks were then
superimposed onto the FA images of each individual animal. Histo-
grams containing 1000 bins were created from the bilateral striatum
and cortex of each rat. To compensate for variability of brain size, each
bin was normalized by the total number of voxels contributing to the
histogram. To reduce the possible effects of local minimum, the histo-
grams from each rat were subjected to a 5-point median smoothing
procedure. Three parameters were then derived from the smoothed
histogram of each subject, including the averaged FA value, histogram
peak height and histogram peak location. Group-averaged histograms
were also calculated for presentation.
The striatum was composed of ﬁber-rich WM-like regions having
high FA values and graymatter (GM)-like regions having low FA values.
To pinpoint the exact locations of the diabetes-induced FA changes, we
divided the ROI representing the whole striatum into two sub-ROIs
based on the averaged FA map from the control group. A cutting FA
value of 0.2 was used to classify each voxel within the striatal mask
into either the high FA sub-ROI or the low FA sub-ROI (Smith et al.,
2006). The averaged DTI indices within the sub-ROIs were calculated
and compared between the control and STZ groups (Fig. 3). Similar
analyses were also conducted for the cortex (Fig. 4).
Statistical analysis
Repeated measures analysis of variance (ANOVA) was used to ana-
lyze body weight and blood glucose data. Two-tailed Student's t-tests
were used to assess the statistical signiﬁcance of inter-group difference
in histogram parameters and diffusion indices. The signiﬁcance level
was set at pb0.05 with Bonferroni correction for multiple comparisons.
Results
Body weight and blood glucose level
Table 1 shows the body weight and fasting blood glucose data. No
statistically signiﬁcant difference in body weight was found between
the groups before saline/STZ treatment, nor in fasting blood glucose
level. The control rats showed increasing body weight over time,
while the STZ group had decreasing body weight. The fasting blood
glucose level in the STZ group was signiﬁcantly higher than that in the
control group at 3 days and the time points after. Repeated measures
ANOVA revealed that the main effects of group, time and group×timeTable 1
Fasting blood glucose level and body weight in control (Con) and STZ-treated animals.
Day 0 Day
Blood glucose (mmol/L) Con (n=16) 4.2±0.6 5.
STZ (n=16) 4.0±0.5 23.
Body weight (g) Con (n=16) 293.3±27.5
STZ (n=16) 300.7±17.3
⁎ Signiﬁcantly different from the control group (pb0.0001, two-sample t-test).interaction were statistically signiﬁcant for both body weight and fasting
blood glucose level.
Voxel-based analysis of DTI data
Fig. 1A shows representative raw diffusion-weighted (b=0 and
800 s/mm2) images acquired from a control animal, as well as a residual
map demonstrating the accuracy of tensor ﬁtting. The results of VBA are
shown in Fig. 1B. Compared to the control animals, the diabetic rats
exhibited signiﬁcant decreases of FA in the bilateral striatum, motor cor-
tex and somatosensory cortex.
Histogram/region of interest analysis of DTI data
Compared to the control group, the STZ group showed a left-shifting
FA histogram in the bilateral striatum (Fig. 2A). The inter-group differ-
ence in histogram peak location (Fig. 2B) was statistically signiﬁcant,
but not the difference in histogram peak height (Fig. 2C). The STZ
group showed signiﬁcantly decreased average striatal FA, which oc-
curred in both the GM-like regions where FAb0.2 and the ﬁber
bundle-dominated region where FA≥0.2 (Fig. 2D). The reduction
of striatal FA in the STZ group was accompanied by a signiﬁcantly de-
creased Da and an unchanged Dr (Fig. 2E and F).
The group-average FA histograms of the bilateral cortex are shown
in Fig. 3A. Compared to the control group, the STZ group had a signiﬁ-
cantly (pb0.05) higher histogram peak height (Fig. 3B), but unchanged
histogram peak location (Fig. 3C). The decrease of cortical FA in the STZ
group appeared to be conﬁned to the WM-like regions where FA≥0.2
(including the molecular layer and the pyramidal layers, Fig. 3D and E).
The changes of FA in the regions with FAb0.2 (including the granular
layers and part of the polymorphic layer) were not statistically signiﬁcant
(Fig. 3D). For the STZ group, the decrease of FA in the cortical regionwith
FA≥0.2was accompanied by a slightly increasedDr and an unchangedDa
(Fig. 3F).
Histopathological changes in striatum
The histopathological changes of the ﬁber bundles in the striatum
of STZ-induced rats included: less staining with LFB (Fig. 4B) and
SMI-31 (Fig. 4D), and sparser/disarranged neuroﬁbrils as revealed
by BS staining (Fig. 4F). The result of both BS staining and methylene
blue staining (arrows in Fig. 4H) indicated vacuole formation in the
striatal ﬁber bundles of the STZ-induced animals. Ultrastructural
analysis of the axons in the striatal ﬁber bundles showed signs of rar-
efaction of myelin sheath (arrows in Fig. 4J), myelin loss (arrowhead
in Fig. 4K) and axonal degradation (asterisk in Fig. 4K).
Histopathological changes in cortex
The histopathological changes in cortex of the STZ-induced ani-
mals included rareﬁed neuropil in the molecular layer (Fig. 5C), dys-
trophic pyramidal neurons exhibiting fewer processes and poorly
BS-stained somas (Fig. 5E and G), and signs of neuronal dystrophia
(arrows in Fig. 5O) or loss (asterisk in Fig. 5M) in the polymorphic
layer. Ultrastructural analysis showed that the pyramidal neurons of
the STZ animals were associated with compromised integrity of the3 Day 7 Day 14 Day 28
4±1.1 3.5±0.5 3.4±0.3 3.7±0.6
6±7.6⁎ 19.0±6.3⁎ 17.3±3.9⁎ 25.9±7.0⁎
322.2±31.0 343.5±30.4 387.6±36.1
268.0±21.7⁎ 250.8±31.5⁎ 230.4±30.2⁎
Fig. 1. Representative raw diffusion-weighted images from a control rat are shown in (A), as well as the corresponding residual map demonstrating the accuracy of tensor ﬁtting.
Panel B shows that the STZ-induced rats had diffuse reduction of FA in bilateral striatum and motor/somatosensory cortex. Pixels with statistical signiﬁcance (t>3, voxel extent
threshold=10) are shown in color and superimposed on the population-speciﬁc FA template generated from 16 control rats and 16 STZ-induced rats. An FA threshold of 0.15 was
used when generating the t map. The color bar in (A) denotes the relative amplitude of the residuals (as percentage of the signal intensity of the corresponding pixel in the raw images).
The color bar in (B) denotes t scores (range 0–8).
Fig. 2. Histogram and region of interest analysis of the diffusion indices in the bilateral striatum. The group-averaged FA histograms of the bilateral striatum (from Bregma 2.52 to
0 mm) are shown in the form of line graphs in A. Compared to the control group (Con), the STZ group (STZ) showed a statistically signiﬁcant (*pb0.001) reduction in histogram
peak location (B), but no change in histogram peak height (C). Compared to the control group, the STZ group showed signiﬁcantly reduced average FA in the whole striatum, the
gray matter-like region with FAb0.2, and the white matter-like region with FA≥0.2 (D, *pb0.001). The reduction of FA in the diabetic striatum was associated with a signiﬁcantly
decreased axial diffusivity (Da, F and G, *pb0.05 vs. Con) and unchanged radial diffusivity (Dr).
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Fig. 3. Histogram and region of interest analysis of the diffusion indices in the bilateral cortex. The group-averaged FA histograms of the bilateral cortex (from Bregma 3.00 to−0.60 mm)
are shown in the formof line graphs in A. Compared to the control group (Con), the STZ group (STZ) showed a statistically signiﬁcant (*pb0.05) increase in histogram peak height (B), but
no change inhistogrampeak location (C). The STZ group showed signiﬁcantly reduced FAonly in the cortical regionwith FA≥0.2 (Dand E). Panel D shows the regionswith FA≥0.2 (in red
color)within the cortexmask. The FA changes in thewhole cortex and cortical regionwith FAb0.2 (including granular layer and partly polymorphic layer)were not statistically signiﬁcant
(E). Panel F demonstrates that the reduction of FA in the cortical regionwith FA≥0.2was associatedwith a slightly increased radial diffusivity (Dr) and an unchanged axial diffusivity (Da).
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fragmentation of neuroﬁlaments in the dendrites (asterisk in Fig. 5K),
mitochondrial abnormalities (arrowheads in Fig. 5I and K) and aggrega-
tion of cellular organelle (circle in Fig. 5K).
Discussion
In the present study, brain injuries in a rat model of STZ-induced
type 1 diabetes were evaluated with DTI. It was shown that, without
glycemic control, the STZ-induced animals developed reduced FA in
the striatum and motor/somatosensory cortex as early as 4 weeks
after induction. Histologically, the brain regions showing FA changes
were associated with demyelination, axonal degradation and neuro-
nal dysfunction/loss.
Diabetes-induced DTI changes
Diffusion indices derived from DTI, such as FA, are widely-used
surrogates for WM microstructural integrity. Clinical studies have
shown that both type 1 diabetic and type 2 diabetic patients are associ-
ated with WM abnormalities observable to DTI. Lower FA values were
found in the posterior corona radiata and the optic radiation of type 1
diabetic patients (Kodl et al., 2008), and in the frontal, temporal and
right caudate WM of type 2 diabetic patients (Hsu et al., 2012; Yau
et al., 2009).
Interestingly, we did not ﬁnd any signiﬁcant FA changes in themajor
WM tracts of diabetic animals. Instead, without glycemic control, the
STZ-induced rats were shown to have signiﬁcantly reduced FA in the bi-
lateral striatum and motor/somatosensory cortex as early as 4 weeks
after induction. The FA reduction in the striatum appeared to be homog-
enous, and accompanied by a signiﬁcantly decreased Da and a slightly in-
creasedDr (Fig. 2). It is generally believed that the increase of Dr inWM is
associated with demyelination (Song et al., 2002, 2005). In contrast, Daappeared to be a marker more closely related to axonal damage
(Sun et al., 2006). Decreased Da has been shown to be associated with
axonal degeneration (i.e., loss of phosphorylated neuroﬁlaments) and
impaired axonal transport (Deboy et al., 2007; Wu et al., 2007). Histo-
logically, the striatal ﬁber bundles in our STZ-induced animals were
characterized by both demyelination and axonal degeneration, consis-
tent with the DTI ﬁndings.
The water diffusion anisotropy in the cortex mainly originates from
the radial pyramidal neurons and the packed arrangement of axons
(Mukherjee et al., 2002). It has also been reported that neuron density
and glial activity can also modulate anisotropic diffusion of water in the
cortex (Beppu et al., 2005; Neil et al., 1998). Unlike the case in the stria-
tum, the cortical changes of FA were not homogenous, but rather con-
ﬁned to layers with high FA values (including the molecular layer, the
pyramidal layer and part of the polymorphic layer, Figs. 1B and 3). The re-
duction of FA in the cortex was mainly caused by an increase in Dr, with-
out apparent changes inDa (Fig. 3). Interestingly, the cortical regionswith
FA reduction appeared to coincide with those showing axonal degrada-
tion and/or neuronal loss. For example, the neuropil in the molecular
layer of the STZ-induced rat appeared to be rareﬁed compared to that
in the control; the neurons in the pyramidal layer of the STZ-induced an-
imals exhibited compromised integrity of the myelin sheath, damaged
neuroﬁlaments in the dendrites and mitochondrial abnormality (Fig. 5).
Therefore degeneration of the pyramidal neurons could have played a
signiﬁcant role in causing the diffusion changes in the cortex.
However, it should be emphasized that the rat striatum and cortex
are heterogenous regions in which WM and GM are mixed together.
Due to the complex tissue conﬁgurations in these regions and the
partial volume effects, it is the most likely that there is more than
one dominant ﬁber orientation within a single striatal/cortical voxel.
Under such circumstances, the calculation of parametric diffusion in-
dices may not be as straightforward as that in major WM tracts, and
could be affected by factors that are not necessarily related to WM
Fig. 4. Histopathological staining of the striatal sections from control rats (Con, panels A, C, E, G and I) and STZ-induced rats (STZ, panels B, D, F, H, J and K), including KB staining (A and B),
SMI immunohistochemistry (C and D), BS staining (E and F), methylene blue staining (G and H) and uranyl acetate-lead citrate staining (I to K). Compared to that of the control rat, the
striatalﬁber bundles in the STZ-induced rats are less intensively stainedwith LFB (B) and SMI-31 (D), and associatedwith disarranged neuroﬁbrils and vacuole formation (arrows in F andH).
Ultrastructural analysis showed that the striatal ﬁber bundles of the STZ-induced animals are characterized by rareﬁedmyelin sheath (arrows in J), myelin loss (arrowhead in K) and signs of
axonal degradation (asterisk in K).
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and Cercignani, 2009). Caution thus should be exercised in linking
diabetic-induced FA, Da and Dr changes to speciﬁc histopathological
mechanisms.
In contrast to the observations in the ratmodel of diabetic ketoacidosis
(Lamet al., 2005), we foundno signiﬁcant reductionof cortical apparent
diffusion coefﬁcient (ADC) in the diabetic rats (data not shown). Cere-
bral edema is the most common complication of diabetic ketoacidosis
(Glaser et al., 2001), which may have contributed to the ADC increase
observed by Lam et al. (2005). In this study, no evident signs of cerebral
edema were observed in the diabetic animals.
Histological changes in diabetic striatum and cortex
The histological changes observed in the striatum and cortex of the
diabetic animals are consistent with the ﬁndings from previous studies,showing that the diabetic brain is associated with demyelination and
axonal injury. For example, smaller cells with reduced myelin content
were found in the cortex of the STZ-induced diabetic animals at
4 weeks (Malone et al., 2006). Hernandez-Fonseca et al. showed
that disarrangement of myelin sheath and oligodendrocyte abnor-
malities can be observed in STZ-induced rats at 8 weeks after induc-
tion (Hernandez-Fonseca et al., 2009). Reductions inmyelin quantity
and loss of oligodendrocytes were observed in both type 1 diabetic rats
and type 2 diabetic rats at 4 months (Yang et al., 2011). In a mice
model of STZ-induced type 1 diabetes, myelin loss occurred in both
WM and GM regions at 8 months after induction (Francis et al., 2008).
On the other hand, impairment of axonal transport in the olfactory
bulbs of the STZ-inducedmice occurs as early as oneweek after induction
(Sharma et al., 2010). It was demonstrated that, after 8 weeks of hyper-
glycemia, the pyramidal cells in the parietal cortex,medial prefrontal cor-
tex and hippocampus of the STZ-induced diabetic rats showed dendritic
Fig. 5. Histopathological staining of the cortical sections from control rats (Con, panels B, D, F, H, J, L and N) and STZ-induced rats (STZ, panels A, C, E, G, I, K, M and O), including BS
staining (A to E), methylene blue staining (F, G, N and O), uranyl acetate-lead citrate staining (H to K) and Nissl staining (L and M). Panel A illustrates the laminar structures of the
cortex. The neuropil in the molecular layer of the STZ-induced rat (C) appeared to be rareﬁed compared to that in control (B). The arrows in D, F and N indicate normal-appearing
neurons in the pyramidal layer and polymorphic layer. The arrow in E indicates the poorly BS-stained soma of a pyramidal neuron, while those in G and O indicate dystrophic neu-
rons. The results of ultrastructural analysis were presented in H–K, in which arrowheads indicate mitochondria, the letter d indicates dendrites, and asterisks indicate
neuroﬁlaments in the dendrites. Compared to the control animals, the neurons in the pyramidal layer of the STZ-induced animals exhibited compromised integrity of the myelin
sheath (arrows in I), mitochondrial abnormality (arrowheads in I and K), loss and/or fragmentation of neuroﬁlaments in the dendrites (K), and cellular organelle aggregation (circle in K).
The asterisks inM indicate regionswith evident neuronal loss in the polymorphic layer.ML:molecular layer; O-GL: outer granular layer; O-PyL: outer pyramidal layer; I-GL: inner granular
layer; I-PyL: inner pyramidal layer; PoL: polymorphic layer, CC: corpus callosum.
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loss) (Malone et al., 2008;Martinez-Tellez et al., 2005). In their ultra-
structural study on STZ-induced type 1 diabetes, Hernandez-Fonseca
et al. showed that the diabetic brain is associated with degenerative
changes of neurons and glia, presynaptic vesicle dispersion in swol-
len axonal boutons and fragmentation of neuroﬁlaments at 8 weeks
(Hernandez-Fonseca et al., 2009).
Clinical relevance of diabetes-induced cortical/striatal damage
Frontal gyrus atrophy may contribute to cognitive dysfunction
(Musen et al., 2006; Wessels et al., 2006, 2007), and striatopathy
may lead to movement disorders and somatosensory abnormalities
in clinical diabetic patients (Abe et al., 2009). It has been suggested
that diabetic brain damage are secondary to vascular complications,
such as increased permeability of microvasculature, high plasma os-
molality and hypoperfusion (Jakus and Rietbrock, 2004). Interesting-
ly, the striatum and frontal cortex, the two regions most affected bySTZ-treatment, are also the regions known to be especially susceptible
to ischemic damage (Lei et al., 1998; Sutherland et al., 1991). In addition,
the pathohistological changes in the striatum and cortex we observed in
the STZ-induced rats showed resemblance towhat had been reported for
rats subjected to chronic cerebral hypoperfusion (Chen et al., 2011;
Shibata et al., 2004). On the other hand, the presence of mitochondrial
abnormalities suggests that glucose neurotoxicity could have also played
a role in causing diabetic brain injuries (Edwards et al., 2010; Russell
et al., 1999).
Limitations to the study
There were several limitations to this study in terms of experimental
design. 1) Ketoacidosis frequently occurs in type 1 diabetic patients
without glycemic control, which can cause brain damage and perma-
nent neurological deﬁcits (Glaser et al., 2001). In this study, the level
of ketone bodies in the plasma of the diabetic rats was not monitored.
Possible occurrence of ketoacidosis cannot be ruled out. However, this
64 M. Huang et al. / NeuroImage: Clinical 1 (2012) 57–65is unlikely since cerebral edema, a hallmark for ketoacidosis, was not
observed in our diabetic rats. 2) Most of the histology and immuno-
histochemistry techniques used in this study (i.e., silver staining, LFB
staining and Nissl staining) are dedicated to detect demyelination
and axonal/neuronal damage. More delicate and sensitive histology/
immunohistochemistry techniquesmay reveal more subtle and speciﬁc
pathological changes associated with diabetic brain damage such as
synaptic loss and abnormal microglia activity (DeVisser et al., 2011;
Idan-Feldman et al., 2011). 3) Given the complexity of WM conﬁgura-
tion in the striatum and cortex, and the fact that only a limited number
of animals were subjected to histology/immunohistology evaluations,
no attempt was made to establish semi-quantitative correlations be-
tween the diabetes-related changes in diffusion indices and speciﬁc
histopathological alterations. 4) Without glycemic control, the gen-
eral conditions of the STZ-induced animals may deteriorate rapidly
(Hoybergs et al., 2008). This is also the reason we performed DTI at
4 weeks after induction, but not at later time points when cognitive
impairments are shown to be prominent (Idan-Feldman et al., 2011).
Further studies are needed to establish whether or not changes of
diffusion measures in the diabetic striatum and cortex animals are
associated with cognitive/motor dysfunction. 5) Further studies on
animal models of type 2 diabetes are needed, so are the studies designed
to investigate the effect of glycemic control on the progress of brain
complications.
There are also some limitationswith respect to the image processing
pipeline used in this study. First, Leemans and Jones have shown that
the b-matrix needs to be adjusted during the correction of eddy cur-
rents and residual motion drifts (Leemans and Jones, 2009), and the in-
tensity of the diffusion data has to be modulated with the Jacobian
determinant due to residual phase-encoding eddy currents (Jones and
Cercignani, 2010). Such steps were not performed in this study and
could have potentially affected the accuracy of tensor ﬁtting.
Second, selection of the type (i.e., isotropic vs. anisotropic) and
kernel size of spatial smoothing is known to inﬂuence the VBA results
on DTI data comparisons. For example, it has been an empirical rule of
thumb that the FWHM should be at least twice the voxel dimension
in order to get statistically robust results (Jones et al., 2005). In addi-
tion, anisotropic smoothing is known to provide better results than
isotropic smoothing when performing VBA on DTI data (Van Hecke
et al., 2010). In this study, we used isotropic smoothingwith a Gaussian
kernel having a FWHM three times the dimension of the voxel size. An-
isotropic smoothingwas not performed due to its technical complexity.
Finally,weused afﬁne transformation in constructing the population-
speciﬁc template and for image spatial co-registration. The use of more
advanced non-rigid co-registration algorithms and tensor reorientation
strategies could potentially give better results by improving the spatial
and orientational alignment of the diffusion tensor images (Van Hecke
et al., 2008, 2011).Conclusion
In conclusion, we showed that, without glycemic control, the STZ-
induced type 1 diabetic rats had brain injuries observable to DTI as
early as 4 weeks after induction. The cerebral abnormalities associated
with STZ-induced type 1 diabetes are characterized by signiﬁcantly
reduced FA in the motor/somatosensory cortex and striatum. The
FA changes in the diabetic cortex and striatum are likely manifesta-
tions of demyelination and axonal degradation in these regions.Acknowledgments
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